Community Oncology Pharmacists: Their Crucial Role and Clinical Impact With Andrea Roman, PharmD, BCOP
Expert Perspectives · Keira Smith · 2024-07-18
At this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, Oncology Data Advisor sat down with Andrea Roman, PharmD, BCOP, a Senior Clinical Pharmacist at McKesson and the US Oncology Network, to discuss her presentation entitled “Clinical impact and financial feasibility of remote oncology pharmacists’ roles in community oncology practices,” with emphasis on:
- The role of oncology-trained pharmacists’ in the community oncology setting
- The US Oncology Network’s novel remote oncology pharmacist model and what it provides
- Results of their study in which oncology-trained pharmacists remotely reviewed chemotherapy regimens across 12 community practices and identified opportunities to modify therapy based on clinical criteria, waste reduction, and financial stewardship
- How their findings were implemented in accordance with practice-approved policies
- What these results highlight about the vital role and impact of community oncology pharmacists
- Opportunities for changes to be made in community oncology practices in light of the study’s results
- And more!
About Dr. Roman
Andrea Roman, PharmD, BCOP, is a Senior Clinical Pharmacist, certified in oncology, at McKesson Specialty Health and the US Oncology Network. Her research focuses on improving community oncology practice by incorporating and collaborating with pharmacists.